Today March 28 the Swedish market close at 13.00. Danish and Norweigan markets is closed.

Redwood Pharma is a pharmaceutical company. The main focus is on the production of ophthalmic pharmaceuticals. The products contain active substances that are used in the treatment of dry eye disease (DED), characterised by dryness, pain, and burning. The disorder is caused by inflammation due to dysfunction of the glands as well as by the usage of contact lenses. The company is based in Stockholm.

Quotes for Redwood Pharma AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Martin Vidaeus

Chairperson of the Board

  • Gunnar Mattsson

Board

  • Hans Ageland
  • Ingrid Atteryd-Heiman
  • Martin Vidaeus
  • Mats Lidgard

Videos

Largest Owners

Name Capital % Votes % Date
Avanza Pension 5,50 5,50 2023-12-27
Arne Andersson 4,58 4,58 2023-12-27
Formue Nord A/S 3,87 3,87 2023-12-27
Oleg Sutjagin 3,01 3,01 2023-12-27
Michael Rönnqvist 1,81 1,81 2023-12-27
Lennart Starby 1,61 1,61 2023-12-27
Michael Hedegaard 1,51 1,51 2023-12-27
Sound & Vision Support I Sverige 1,41 1,41 2023-12-27
Martin Johem 1,32 1,32 2023-12-27
Christian Lentz 1,32 1,32 2023-12-27